![Rebecca Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rebecca Lin
Directeur/Bestuurslid bij
Shanghai Rarestone Health Tech Group Co. Ltd.
Profiel
Rebecca Lin is currently a Director at Shanghai Rarestone Health Tech Group Co., Ltd. and a Senior Partner & Co Head at Eight Roads Capital Advisors (CHINA) since 2021.
Education includes an undergraduate degree from Shenzhen University conferred in 1994 and an MBA from The Wharton School of the University of Pennsylvania conferred in 2000.
Actieve functies van Rebecca Lin
| Bedrijven | Functie | Begin |
|---|---|---|
Eight Roads Capital Advisors (CHINA)
 Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01-06-2007 |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Directeur/Bestuurslid | - |
Opleiding van Rebecca Lin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Shenzhen University
 Shenzhen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Health Technology |
